SE8502525D0 - 1,3-oxazolidine-2-one derivatives and processes for their preparation - Google Patents

1,3-oxazolidine-2-one derivatives and processes for their preparation

Info

Publication number
SE8502525D0
SE8502525D0 SE8502525A SE8502525A SE8502525D0 SE 8502525 D0 SE8502525 D0 SE 8502525D0 SE 8502525 A SE8502525 A SE 8502525A SE 8502525 A SE8502525 A SE 8502525A SE 8502525 D0 SE8502525 D0 SE 8502525D0
Authority
SE
Sweden
Prior art keywords
oxazolidine
derivatives
processes
preparation
medicinal
Prior art date
Application number
SE8502525A
Other languages
English (en)
Other versions
SE463100B (sv
SE8502525L (sv
Inventor
M Masaki
H Shinozaki
M Satoh
N Moritoh
K Hashimoto
T Kamishiro
Original Assignee
Nippon Chemiphar Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co filed Critical Nippon Chemiphar Co
Publication of SE8502525D0 publication Critical patent/SE8502525D0/sv
Publication of SE8502525L publication Critical patent/SE8502525L/sv
Publication of SE463100B publication Critical patent/SE463100B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE8502525A 1984-09-28 1985-05-22 1,3-oxazolidin-2-on-derivat och foerfaranden foer framstaellning daerav SE463100B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59203624A JPS6183170A (ja) 1984-09-28 1984-09-28 新規な１，３−オキサゾリジン−２−オン誘導体およびその製造法

Publications (3)

Publication Number Publication Date
SE8502525D0 true SE8502525D0 (sv) 1985-05-22
SE8502525L SE8502525L (sv) 1986-03-29
SE463100B SE463100B (sv) 1990-10-08

Family

ID=16477122

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8502525A SE463100B (sv) 1984-09-28 1985-05-22 1,3-oxazolidin-2-on-derivat och foerfaranden foer framstaellning daerav

Country Status (27)

Country Link
US (1) US4644063A (sv)
JP (1) JPS6183170A (sv)
KR (1) KR900004323B1 (sv)
AR (1) AR240924A1 (sv)
AT (1) AT392069B (sv)
AU (1) AU566419B2 (sv)
BR (1) BR8502707A (sv)
CA (1) CA1252092A (sv)
CH (1) CH663207A5 (sv)
CS (1) CS273606B2 (sv)
DE (1) DE3519261C2 (sv)
DK (1) DK165952C (sv)
ES (2) ES8800571A1 (sv)
FR (1) FR2571052B1 (sv)
GB (2) GB8512975D0 (sv)
HU (1) HU199132B (sv)
IN (1) IN162060B (sv)
IT (1) IT1208807B (sv)
MX (2) MX161397A (sv)
MY (1) MY102081A (sv)
NL (1) NL193191C (sv)
NZ (1) NZ212143A (sv)
PH (1) PH20852A (sv)
RO (1) RO91422B (sv)
SE (1) SE463100B (sv)
SU (2) SU1402263A3 (sv)
ZA (1) ZA854001B (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6183147A (ja) * 1984-09-28 1986-04-26 Nippon Chemiphar Co Ltd 新規なアミノアルコール誘導体およびその製造法並びにそれを有効成分とするグルタミン酸遮断剤
JPH0759570B2 (ja) * 1986-05-06 1995-06-28 三井東圧化学株式会社 ２−オキサゾリジノン類の製造方法
JPH0713017B2 (ja) * 1986-06-18 1995-02-15 日本ケミファ株式会社 脳細胞保護作用を有する医薬組成物
DE3877470T2 (de) * 1987-09-10 1993-06-24 Merck Sharp & Dohme Oxazole und thiazole zur behandlung seniler demenz.
ATE106243T1 (de) * 1988-03-24 1994-06-15 Sankyo Co Verwendung von isoxazolinonen als cerebro-aktive medikamente.
JPH0314562A (ja) * 1988-04-11 1991-01-23 Nippon Chemiphar Co Ltd 新規なアルキレンジアミン誘導体およびグルタミン酸遮断剤
US5187171A (en) * 1989-01-09 1993-02-16 G. D. Searle & Co. Use of a glycine b partial agonist as an antipsychotic
ATE170516T1 (de) * 1992-07-14 1998-09-15 Nippon Chemiphar Co Alkylendiaminderivate
US5698573A (en) * 1993-09-15 1997-12-16 Merck, Sharp & Dohme, Ltd. Imidazolone and oxazolone derivatives as dopamine antagonists
DE4425613A1 (de) * 1994-07-20 1996-01-25 Bayer Ag 5-gliedrige Heteroaryl-oxazolidinone
US6037354A (en) * 1997-06-18 2000-03-14 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonists
US9717239B2 (en) 2013-03-14 2017-08-01 Akzo Nobel Chemicals International B.V. Cellulose ether as a drift control agent and rainfastness agent

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2437389A (en) * 1948-03-09 Oxazoeidones and erocesstok
DE1135461B (de) * 1959-05-08 1962-08-30 Knoll Ag Verfahren zur Herstellung von basisch substituierten Phthalimidinen
FR1301267A (fr) * 1961-04-04 1962-08-17 Science Union Et Compagnie Soc Nouveaux dérivés de l'oxazolidinone-2 et leurs procédés de préparation
US3131197A (en) * 1963-03-13 1964-04-28 Smith Kline French Lab 5-(3, 4-carbonyldioxyphenyl)-3-isopropyl-2-oxazolidone
US3576808A (en) * 1967-09-15 1971-04-27 Miles Lab N-4-phenyl-1-piperazinylalkyl-5-phenyl-oxazolidinones
GB1222708A (en) * 1968-10-22 1971-02-17 Delalande Sa Novel 5-(n-substituted aminomethyl)-2-oxazolidinones and their process of preparation
FR2179582B1 (sv) * 1972-04-13 1975-10-10 Synthelabo

Also Published As

Publication number Publication date
ES557075A0 (es) 1988-04-01
GB2165237A (en) 1986-04-09
ATA165685A (de) 1990-07-15
HUT39168A (en) 1986-08-28
AU4469785A (en) 1986-04-10
PH20852A (en) 1987-05-19
JPH0469150B2 (sv) 1992-11-05
GB8512975D0 (en) 1985-06-26
JPS6183170A (ja) 1986-04-26
IT8567500A0 (it) 1985-05-30
NL8501579A (nl) 1986-04-16
SU1431679A3 (ru) 1988-10-15
GB8513685D0 (en) 1985-07-03
RO91422A (ro) 1987-06-30
AU566419B2 (en) 1987-10-22
GB2165237B (en) 1987-12-09
US4644063A (en) 1987-02-17
CS273606B2 (en) 1991-03-12
ES8802152A1 (es) 1988-04-01
IT1208807B (it) 1989-07-10
AT392069B (de) 1991-01-25
SU1402263A3 (ru) 1988-06-07
DE3519261A1 (de) 1986-04-10
CH663207A5 (fr) 1987-11-30
AR240924A2 (es) 1991-03-27
CS392785A2 (en) 1990-08-14
DK165952B (da) 1993-02-15
KR900004323B1 (ko) 1990-06-22
HU199132B (en) 1990-01-29
MY102081A (en) 1992-03-31
KR860002502A (ko) 1986-04-26
DE3519261C2 (de) 1997-01-16
MX21592A (es) 1994-01-31
CA1252092A (en) 1989-04-04
NL193191B (nl) 1998-10-01
ES543517A0 (es) 1987-11-01
SE463100B (sv) 1990-10-08
MX161397A (es) 1990-09-20
NZ212143A (en) 1987-11-27
RO91422B (ro) 1987-07-02
DK230185A (da) 1986-03-29
NL193191C (nl) 1999-02-02
BR8502707A (pt) 1986-05-27
SE8502525L (sv) 1986-03-29
ZA854001B (en) 1986-01-29
DK165952C (da) 1993-07-05
FR2571052B1 (fr) 1988-03-04
FR2571052A1 (fr) 1986-04-04
IN162060B (sv) 1988-03-19
AR240924A1 (es) 1991-03-27
DK230185D0 (da) 1985-05-23
ES8800571A1 (es) 1987-11-01

Similar Documents

Publication Publication Date Title
ES509242A0 (es) "procedimiento para preparar nuevos compuestos de cefem".
SE8503922D0 (sv) Analgesic 1,2-benzisothiazol-3-ylpiperazine derivatives
SE8601907L (sv) Antitrombogena och kardiotoniska imidazokinoliner
MX5680E (es) Procedimiento para la preparacion de 2-(2-alcoxietil)-2'-hidroxi-6,7-benzomorfanos
SE8804586L (sv) 1,4-dihydro-4-oxonaftyridinderivat och salter daerav foerfarande foer framstaellning av dessa jaemte antibakteriella medel innefattande dessa
ATE25078T1 (de) 2-amino-3-acylamino-6-benzylamino-pyridinderivate mit anti-epileptischer wirkung.
SE7714592L (sv) Cyklopentan-1-aminer, forfarande for framstellning derav och medel innehallande dessa foreningar
ATE50559T1 (de) Substituierte p,p'-methylen-bis-aniline.
SE8502525D0 (sv) 1,3-oxazolidine-2-one derivatives and processes for their preparation
DE3360904D1 (de) A fungicidal indanylbenzamide
ES528452A0 (es) Procedimiento de preparacion de nuevos derivados dietilaminoalcoxibenzoles y de sus sales de adicion acidas y amonicas cuaternarias
DK178883A (da) 2-(2'-hydroxy-3'-(1,1-dimethylpropylamino)-propoxy)-beta-phenylpropiophenon, syreadditionssalte deraf, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater med indhold deraf
SE8405123L (sv) Forfarande for framstellning av pyrrolidin- eller pyridinkarboxylsyraderivat
ES515872A0 (es) "procedimiento para la preparacion de nuevos derivados de acidos 4-fenoxialcarboxilicos sustituidos con radicales haterociclicos".
ZA871757B (en) 1-phenylimidazolecarboxylic acid amides,their preparation and their use as growth regulators
ES510739A0 (es) "procedimiento para la preparacion de 1,1-dioxidos de 4-hidroxi-1,2-benzoisotiazol-3(2h)-ona".
JPS53124267A (en) 1-alkoxyacyl-3-(3,5-dihalogenophenyl)hydantoin derivatives, their preparation and bactericides for agricultural and horticultural uses containing the same as active agent
DE3861545D1 (de) Aminoverbindungen und diese enthaltende fungizide.
ES515201A0 (es) "procedimiento para la fabricacion de derivados n- susbtituidos de la tetrahidroisftalimida".
JPS5427564A (en) 1-branched alkylcarbonyl-3-(3,5-dihalogenophenyl) hydantoins, their preparation, and bactericides for pomicultural and horticultural uses containing the same as active agent.
DK601883D0 (da) Phenyl-propanolderivater
SE7908820L (sv) Imidazolyletoxiderivat av pyridin-5-metanoler och kinolin-3-metanoler

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8502525-2

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8502525-2

Format of ref document f/p: F